REQUEST A DEMO
Total
USD $0.00
Search more companies

Alborz Investment Group Company Public Joint Stock (Iran)

Main Activities: Other Financial Investment Activities | Management of Companies and Enterprises
Full name: Alborz Investment Group Company Public Joint Stock Profile Updated: March 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Alborz Investment Group Company Public Joint Stock, located in Tehran, was founded under the name "Yekdel" on December 24th, 1966. It was initially registered as a public company and later became a private joint stock company on October 20th, 1971. In July 25th, 1974, it was converted back to a public company and its name was changed to Alborz Investigation Co. The main activity of Alborz Investment Group is investing and contributing in firms, production, commercial and construction companies, as well as trading securities and engaging in any legal commercial activity related to the company's scope. Alborz Investment Group was established in 1966 with a focus on the production and distribution of medicines, detergents, and foodstuff. Over the years, the company has become a leading and innovative group. Some of its important companies include Tolid Darou, Iran Darou, KBC, Toli Pers, Keyvan, and Pakhsh Alborz. These companies are involved in the manufacturing of pharmaceutical, cosmetic, and health products, as well as confectionery and distribution of health products. In recent years, Alborz Investment Group has shifted its focus to the pharmaceutical industry and has developed a production chain consisting of raw material production and product distribution. The company is listed on the Tehran Stock Exchange and has over 18,000 real and legal shareholders, 13 reputable subsidiary companies listed on the Stock Exchange, and more than 3,200 skilled and experienced personnel. Alborz Investment Group plays a significant role in the production and supply of pharmaceuticals in Iran.

Headquarters
Arzhantin Square, Ahmed Qasir St, No.11, Fifth Street
Tehran; Tehran; Postal Code: 1513718111

Contact Details: Purchase the Alborz Investment Group Company Public Joint Stock report to view the information.

Website: http://www.alborzinvest.ir

Basic Information
Total Employees:
Purchase the Alborz Investment Group Company Public Joint Stock report to view the information.
Outstanding Shares:
Purchase the Alborz Investment Group Company Public Joint Stock report to view the information.
Financial Auditors:
Purchase the Alborz Investment Group Company Public Joint Stock report to view the information.
Incorporation Date:
1966
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
4.81%
Purchase this report to view the information.
3.2%
Purchase this report to view the information.
1.85%
Purchase this report to view the information.
1.67%
Purchase this report to view the information.
0.93%
Subsidiaries
Pakhsh Alborz Company Public Joint Stock
62%
Toliddaru Pharmaceutical Company Public Joint Stock
54%
Etela Alborz Investment Company Public Joint Stock
52%
Company Performance
Financial values in the chart are available after Alborz Investment Group Company Public Joint Stock report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IRR. Absolute financial data is included in the purchased report.
Operating profit (EBIT)
N/A
Net Profit (Loss) for the Period
73.66%
Total assets
22.08%
Total equity
23.45%
Return on Equity (ROE)
4.25%
Quick Ratio
-0.11%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?